Advisers debate safety of allowing over-the-counter sales of cholesterol drug
An FDA advisory panel is expected to make its recommendation today on whether a cholesterol drug should be sold over the counter. The drug Mevacor lowers cholesterol by limiting the buildup of artery-clogging fat deposits. It also reduces the risk of heart attack by about a third. Sponsors who want Mevacor available without a prescription say the drug could help millions of Americans who are at moderate risk of heart disease.